Trials / Completed
CompletedNCT05550129
Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants
A Phase I, Open-label Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The primary objectives of this study are to evaluate the effect of AMG 510 on the pharmacokinetics (PK) of metformin in healthy participants and to evaluate the effect of metformin on the PK of AMG 510 in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AMG 510 | Oral tablet |
| DRUG | Metformin | Oral tablet |
Timeline
- Start date
- 2019-11-13
- Primary completion
- 2019-11-25
- Completion
- 2019-11-25
- First posted
- 2022-09-22
- Last updated
- 2025-03-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05550129. Inclusion in this directory is not an endorsement.